MENOPAUSAL TRANSITION AND MENOPAUSAL SYNDROME IN WOMEN AFTER THE COVID-19
Keywords:
COVID-19, Perimenopausal period, Women's health, Menopausal hormone therapy, PhytoestrogensAbstract
In the last decade, the concept of "active longevity" has been actively promoted, where a special place is occupied by the age aspects of women's health. The perimenopausal period of women's life is due to the consequences of estrogen deficiency, which in turn leads to physiological changes and diseases of other systems. The protection of menopausal hormone therapy improves the background state of the immune system and the coagulation system, increasing additional mechanisms for protecting the vascular wall. However, in the context of the ongoing COVID-19, many open questions arise regarding the prescription of menopausal hormone therapy, primarily the degree of their effectiveness and safety in SARS CoV-2. The answers to these questions are ambiguous due to the insufficient scientific evidence base and remain relevant.
References
Адамян Л. В. COVID-19 и женское здоровье (обзор литературы) / Л. В. Адамян, Я. Б. Азнаурова, О. С. Филиппов //Problemy Reproduktsii. – 2020. – Т. 26, №. 2. – С. 112 – 115.
The effect of COVID-19 on the menstrual cycle: a systematic review / V. Lebar et al. //Journal of Clinical Medicine. – 2022. – Т. 11, №. 13. – P. 3800.
Марченкова Л. А. Особенности течения COVID-19 у женщин в пери-и постменопаузе. Роль менопаузальной гормональной терапии / Л. А. Марченкова, Е. В. Макарова //Вопросы гинекологии, акушерства и перинатологии. – 2022. – Т. 21, №. 1. – С. 85.
Гаспарян С. А. Когнитивные и психоэмоциональные нарушения у женщин периода менопаузального перехода: возможности медикаментозной коррекции / С. А. Гаспарян, А. М. Чотчаева, Карпов С. М. //Проблемы Эндокринологии. – 2023. – Т. 69. – №. 1. – С. 86-95.
Estrogen and COVID-19 symptoms: associations in women from the COVID Symptom Study / R. Costeira et al. //PLoS One. – 2021. – Т. 16. – №. 9. – P. 2570.
Амбулаторные подходы к лечению новой коронавирусной инфекции у беременных и кормящих женщин / А. В. Мордык и др. //Лечащий врач. – 2020. – №. 8. – С. 71-76.
Восстановление репродуктивного здоровья женщин после перенесенной новой коронавирусной инфекции (COVID-19). Некоторые аспекты / Л. В. Адамян и др. //Проблемы репродукции. – 2020. – Т. 26, №. 4. – С. 6-13.
Evaluation of the presence of SARS-COV-2 in the vaginal fluid of reproductive-aged women / H. U. Yuvacı et al. //Ginekologia Polska. – 2021. – Т. 92, №. 6. – P. 406-409.
Changes in menopausal risk factors in early postmenopausal osteopenic women after 13 months of high-intensity exercise: The randomized controlled ACTLIFE-RCT / M. Hettchen et al. //Clinical Interventions in Aging. – 2021. – №2. - P. 83-96.
Clinical and genetic aspects of menopausal hormone therapy-a modern paradigm. What changed COVID-19 pandemic? / I. S. Zhuravleva et al. //RUDN Journal of Medicine. – 2022. – Т. 26, №. 4. – P. 364-372.
Pyle W. G. Sex, cardiovascular disease, and the inequities of COVID-19 / W. G. Pyle //American Journal of Physiology-Heart and Circulatory Physiology. – 2022. – Т. 323. – №. 3. – P. 535-537.
Could estrogen protect women from COVID-19? / R. Pirhadi et al. //Journal of clinical medicine research. – 2020. – Т. 12, №. 10. – P. 634.
COVID-19 risk perception and coping mechanisms: Does gender make a difference? / I. A. Rana et al. //International Journal of Disaster Risk Reduction. – 2021. – Т. 55. – P. 102096.
COVID-19 gender susceptibility and outcomes: A systematic review / I. Lakbar et al. //PLoS One. – 2020. – Т. 15, №. 11. – P. 241.
The internet hospital plus drug delivery platform for health management during the COVID-19 pandemic: observational study / L. Ding et al. //Journal of Medical Internet Research. – 2020. – Т. 22, №. 8. – P. 1967.
Strope J. D. Are sex discordant outcomes in COVID-19 related to sex hormones? / J. D. Strope, C. H. Chau, W. D. Figg //Seminars in oncology. – WB Saunders, 2020. – Т. 47, №. 5. – P. 335-340.
Interaction of metals, menopause and COVID-19—a review of the literature / T. Męcik-Kronenberg et al. //Biology. – 2023. – Т. 12, №. 3. – P. 350.
Depression among Peri-and Post-Menopausal women during COVID-19 pandemic in Chandigarh, North India: A study from community / S. Khatak et al. //Journal of Mid-life Health. – 2022. – Т. 13, №. 3. – P. 233.
Power K. The COVID-19 pandemic has increased the care burden of women and families / K. Power //Sustainability: Science, Practice and Policy. – 2020. – Т. 16, №. 1. – P. 67-73.
Hormone therapy in the era of the COVID-19 pandemic: a review/ S. W. Choi et al. //Journal of Menopausal Medicine. – 2022. – Т. 28, №. 1. – P. 1.
Higher perceived stress during the COVID-19 pandemic increased menstrual dysregulation and menopause symptoms / R. G. de Leon et al. //medRxiv. – 2022. – №1. - P. 213.
Gersh F. Menopause status and coronavirus disease 2019 (COVID-19) / F. Gersh, C. J. Lavie, J. H. O’Keefe //Clinical Infectious Diseases. – 2021. – Т. 73, №. 9. – P. 2825-2826.
Печенкина Е. Д. Гендерное неравенство в России и странах Запада: усугубление ситуации во время пандемии COVID-19 / Е. Д. Печенкина //Вестник Удмуртского университета. Социология. Политология. Международные отношения. – 2021. – Т. 5, №. 3. – С. 381-390.
Поражение мышечной системы при COVID-19 / И. Т. Муркамилов и др. //Архивъ внутренней медицины. – 2021. – Т. 11, №. 2 (58). – С. 146-153.
Thomas N. Sex differences and COVID-19 / N. Thomas, C. Gurvich, J. Kulkarni //Identification of Biomarkers, New Treatments, and Vaccines for COVID-19. – 2021. – P. 79-91.
